Published in Proc Natl Acad Sci U S A on July 23, 1996
Mammalian kidney development: principles, progress, and projections. Cold Spring Harb Perspect Biol (2012) 1.80
Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. EMBO J (2000) 1.69
WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes Dev (1998) 1.50
Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci U S A (1997) 1.23
Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1. Genes Dev (2001) 1.20
NRP/B, a novel nuclear matrix protein, associates with p110(RB) and is involved in neuronal differentiation. J Cell Biol (1998) 1.18
Wt1a, Foxc1a, and the Notch mediator Rbpj physically interact and regulate the formation of podocytes in zebrafish. Dev Biol (2011) 1.17
WT1 maintains adrenal-gonadal primordium identity and marks a population of AGP-like progenitors within the adrenal gland. Dev Cell (2013) 1.16
The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron. Genes Dev (2006) 1.11
Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein. Proc Natl Acad Sci U S A (2000) 1.10
WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am J Pathol (1999) 1.04
Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance. J Am Soc Nephrol (2015) 0.95
Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA. Mol Cell Biol (2000) 0.94
Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product. Nucleic Acids Res (1998) 0.92
The predominant WT1 isoform (+KTS) encodes a DNA-binding protein targeting the planar cell polarity gene Scribble in renal podocytes. Mol Cancer Res (2010) 0.86
Oxygen-Dependent Gene Expression in Development and Cancer: Lessons Learned from the Wilms' Tumor Gene, WT1. Front Mol Neurosci (2011) 0.85
The role of zinc finger linkers in p43 and TFIIIA binding to 5S rRNA and DNA. Nucleic Acids Res (1998) 0.83
Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression. J Neurooncol (2010) 0.81
TBX3 regulates splicing in vivo: a novel molecular mechanism for Ulnar-mammary syndrome. PLoS Genet (2014) 0.80
BORIS/CTCFL is an RNA-binding protein that associates with polysomes. BMC Cell Biol (2013) 0.79
Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation. Hum Mol Genet (2014) 0.79
Molecular and genetic basis of inherited nephrotic syndrome. Int J Nephrol (2011) 0.78
Alternative splicing regulates Prdm1/Blimp-1 DNA binding activities and corepressor interactions. Mol Cell Biol (2012) 0.78
New clues to the puzzle of mammalian sex determination. Genome Biol (2001) 0.77
How mRNA is misspliced in acute myelogenous leukemia (AML)? Oncotarget (2014) 0.77
Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype. Br J Cancer (1998) 0.77
A genome-wide detection of copy number variation using SNP genotyping arrays in Beijing-You chickens. Genetica (2014) 0.76
WT1 expression is increased in primary fibroblasts derived from Dupuytren's disease tissues. J Cell Commun Signal (2015) 0.76
The zinc fingers of YY1 bind single-stranded RNA with low sequence specificity. Nucleic Acids Res (2016) 0.76
Wilms Tumor Suppressor, WT1, Cooperates with MicroRNA-26a and MicroRNA-101 to Suppress Translation of the Polycomb Protein, EZH2, in Mesenchymal Stem Cells. J Biol Chem (2015) 0.75
Dmy initiates masculinity by altering Gsdf/Sox9a2/Rspo1 expression in medaka (Oryzias latipes). Sci Rep (2016) 0.75
Transcription factor Wilms' tumor 1 regulates developmental RNAs through 3' UTR interaction. Genes Dev (2017) 0.75
Selective inhibition of c-Myb DNA-binding by RNA polymers. BMC Biochem (2004) 0.75
Denys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modifications. Nucleic Acids Res (2016) 0.75
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res (1984) 86.56
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell (1990) 8.30
WT-1 is required for early kidney development. Cell (1993) 7.05
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature (1990) 5.13
Krüppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci U S A (1994) 4.84
Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science (1990) 3.37
Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science (1991) 3.06
BM28, a human member of the MCM2-3-5 family, is displaced from chromatin during DNA replication. J Cell Biol (1995) 3.02
Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci U S A (1991) 2.83
Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell (1995) 2.63
Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science (1992) 2.50
Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development (1993) 2.02
WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J (1995) 2.02
Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci U S A (1993) 1.96
Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature (1995) 1.87
Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science (1992) 1.71
Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci U S A (1993) 1.59
A human nuclear protein with sequence homology to a family of early S phase proteins is required for entry into S phase and for cell division. J Cell Sci (1994) 1.56
Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc Natl Acad Sci U S A (1992) 1.51
The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J Biol Chem (1993) 1.48
Repression of Pax-2 by WT1 during normal kidney development. Development (1995) 1.44
The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem (1992) 1.41
Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene (1991) 1.40
WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J Biol Chem (1995) 1.33
Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations. Genes Dev (1990) 1.32
Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. Mol Endocrinol (1994) 1.27
Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol Cell Biol (1995) 1.27
Evolution of insulin-like growth factor II: characterization of the mouse IGF-II gene and identification of two pseudo-exons. DNA Cell Biol (1990) 1.26
A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1. Proc Natl Acad Sci U S A (1993) 1.26
DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1. Mol Cell Biol (1994) 1.20
Discriminating translation of insulin-like growth factor-II (IGF-II) during mouse embryogenesis. Mol Reprod Dev (1994) 1.11
WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene (1995) 1.11
The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem (1994) 1.11
Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc Natl Acad Sci U S A (1994) 1.08
DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations. Hum Mol Genet (1995) 1.00
Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1. Oncogene (1995) 1.00
Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum Mol Genet (1993) 0.99
A rodent model for Wilms tumors: embryonal kidney neoplasms induced by N-nitroso-N'-methylurea. Proc Natl Acad Sci U S A (1994) 0.95
TFIIIA: nine fingers--three hands? Trends Biochem Sci (1993) 0.87
Transactivation of mouse insulin-like growth factor II (IGF-II) gene promoters by the AP-1 complex. Nucleic Acids Res (1993) 0.82
Repression of promoters for the mouse insulin-like growth factor II-encoding gene (Igf-2) by products of the Wilms' tumour suppressor gene wt1. Gene (1995) 0.80
A luciferase-reporter vector with blue-white selection for rapid subcloning and mutational analysis of eukaryotic promoters. Gene (1993) 0.79
The excretion of vitamin C in human urine and its dependence on the dietary intake. Biochem J (1933) 22.45
DISTURBANCES OF VISION BY CEREBRAL LESIONS. Br J Ophthalmol (1918) 8.56
Complementary medicine in Europe. BMJ (1994) 7.70
Mouse small eye results from mutations in a paired-like homeobox-containing gene. Nature (1992) 6.32
Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region. Cell (1991) 5.84
The expression of three abundance classes of messenger RNA in mouse tissues. Cell (1976) 5.58
Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res (1989) 4.72
Generalized equations for predicting body density of women. Med Sci Sports Exerc (1980) 4.21
DISTURBANCES OF VISUAL ORIENTATION. Br J Ophthalmol (1918) 3.82
A comparative analysis of four protocols for maximal treadmill stress testing. Am Heart J (1976) 3.43
Complete amino acid sequence of beta-tubulin from porcine brain. Proc Natl Acad Sci U S A (1981) 3.24
Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer (2001) 3.21
Telomeric repeat from T. thermophila cross hybridizes with human telomeres. Nature (1988) 3.20
Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities. Cell (1996) 3.01
Complete amino acid sequence of alpha-tubulin from porcine brain. Proc Natl Acad Sci U S A (1981) 2.82
YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development (1999) 2.71
Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell (1995) 2.63
Extensive telomere repeat arrays in mouse are hypervariable. Nucleic Acids Res (1990) 2.56
Multiple genes coding for the androgen-regulated major urinary proteins of the mouse. Cell (1979) 2.52
Accelerated evolution in the reactive centre regions of serine protease inhibitors. Nature (1987) 2.40
Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet (1997) 2.38
Estimation of VO2max from a one-mile track walk, gender, age, and body weight. Med Sci Sports Exerc (1987) 2.34
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1988) 2.27
Defective mitosis due to a mutation in the gene for a fission yeast 26S protease subunit. Nature (1993) 2.26
The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech Dev (1993) 2.26
Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc Natl Acad Sci U S A (2001) 2.24
Comparative analysis of physiologic responses to three different maximal graded exercise test protocols in healthy women. Am Heart J (1982) 2.23
Use of the Pediatric Symptom Checklist to screen for psychosocial problems in pediatric primary care: a national feasibility study. Arch Pediatr Adolesc Med (1999) 2.23
Jellyfish responsible for Irukandji syndrome. QJM (2006) 2.18
DISTURBANCES OF VISUAL ORIENTATION. Br J Ophthalmol (1918) 2.12
Pattern of serum protein gene expression in mouse visceral yolk sac and foetal liver. EMBO J (1984) 2.09
The gene family for major urinary proteins: expression in several secretory tissues of the mouse. Cell (1983) 2.09
Most highly repeated dispersed DNA families in the mouse genome. Mol Cell Biol (1984) 2.04
Relationship between hunger and psychosocial functioning in low-income American children. J Am Acad Child Adolesc Psychiatry (1998) 2.00
Hunger in children in the United States: potential behavioral and emotional correlates. Pediatrics (1998) 1.99
Analysis of mRNA populations by cDNA.mRNA hybrid-mediated inhibition of cell-free protein synthesis. Proc Natl Acad Sci U S A (1978) 1.92
Pressure immobilisation bandages in first-aid treatment of jellyfish envenomation: current recommendations reconsidered. Med J Aust (2001) 1.88
miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene (2010) 1.82
Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1986) 1.75
Race, presenting signs and symptoms, use of carotid artery imaging, and appropriateness of carotid endarterectomy. Stroke (1999) 1.73
Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula. J Antimicrob Chemother (2004) 1.72
Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res (2000) 1.72
Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science (1992) 1.71
A conditional lethal mutant in the fission yeast 26 S protease subunit mts3+ is defective in metaphase to anaphase transition. J Biol Chem (1996) 1.70
Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc Natl Acad Sci U S A (2001) 1.69
Estimating human inbreeding coefficients: comparison of genealogical and marker heterozygosity approaches. Ann Hum Genet (2006) 1.68
Developmentally regulated mRNAs in mouse liver. Proc Natl Acad Sci U S A (1982) 1.66
A bacterial halidohydrolase. Its purification, some properties and its modification by specific amino acid reagents. Eur J Biochem (1971) 1.64
The demand for eating disorder care. An epidemiological study using the general practice research database. Br J Psychiatry (1996) 1.63
Developmental and behavioural outcome in obstetric brachial plexus palsy. J Hand Surg Br (2000) 1.63
Regulation of growth and metabolism by imprinted genes. Cytogenet Genome Res (2006) 1.63
Abortive Muscular Dystrophy. Proc R Soc Med (1909) 1.60
Mapping the structural genes coding for the major urinary proteins in the mouse: combined use of recombinant inbred strains and somatic cell hybrids. Proc Natl Acad Sci U S A (1982) 1.60
A fission yeast chromosome can replicate autonomously in mouse cells. Cell (1987) 1.60
Disturbances of Vision from Cerebral Lesions, with Special Reference to the Cortical Representation of the Macula. Proc R Soc Med (1916) 1.59
Human telomeres: fusion and interstitial sites. Trends Genet (1989) 1.58
CpG methylation regulates the Igf2/H19 insulator. Curr Biol (2001) 1.55
YAC transgenic analysis reveals Wilms' tumour 1 gene activity in the proliferating coelomic epithelium, developing diaphragm and limb. Mech Dev (1998) 1.54
Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs (1986) 1.53
Fish shoal composition: mechanisms and constraints. Proc Biol Sci (2000) 1.50
WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes Dev (1998) 1.50
Epidemiological and surgical aspects of urogenital fistulae: a review of 25 years' experience in southeast Nigeria. Int Urogynecol J Pelvic Floor Dysfunct (1998) 1.50
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature. Prostate Cancer Prostatic Dis (2011) 1.50
Equivalent expression of paternally and maternally inherited WT1 alleles in normal fetal tissue and Wilms' tumours. Oncogene (1992) 1.50
The Pediatric Symptom Checklist. Support for a role in a managed care environment. Arch Pediatr Adolesc Med (1995) 1.48
Plasma protease inhibitors in mouse and man: divergence within the reactive centre regions. Nature (1984) 1.48
Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases at a Portuguese hospital: TEM-10 as the endemic enzyme. J Antimicrob Chemother (2000) 1.48
Wt1 and retinoic acid signaling are essential for stellate cell development and liver morphogenesis. Dev Biol (2007) 1.47
Monocular and binocular depth discrimination thresholds. Optom Vis Sci (1999) 1.45
Chronic psychological effects of exercise and exercise plus cognitive strategies. Med Sci Sports Exerc (1995) 1.44
Nabilone. A preliminary review of its pharmacological properties and therapeutic use. Drugs (1985) 1.44
T lymphocyte subpopulations in anorexia nervosa and refeeding. Clin Immunol Immunopathol (1997) 1.43
Histological observations of bovine tuberculosis in lung and lymph node tissues from British deer. Vet J (2007) 1.42
Arterial complications of the thoracic outlet syndrome: fifty-five operative cases. J Vasc Surg (1989) 1.39
Inhibition of influenza virus replication by -amanitin: mode of action. Proc Natl Acad Sci U S A (1972) 1.39
Access of the black urban elderly to medical care. J Natl Med Assoc (1983) 1.39
Lessons to be learned: a case study approach. An unusual case of alveolar deposition from swallowing metallic mercury in an attempt at self-poisoning. J R Soc Promot Health (1998) 1.38
Cross-talk in kidney development. Curr Opin Genet Dev (2000) 1.38
Construction of a small Mus musculus repetitive DNA library: identification of a new satellite sequence in Mus musculus. Nucleic Acids Res (1983) 1.36
A surface expression vector for antibody screening. Gene (1991) 1.36
MCM proteins are associated with RNA polymerase II holoenzyme. Mol Cell Biol (1999) 1.35
Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs (1987) 1.33
Prognostic value of the electroencephalogram in neonatal asphyxia. Electroencephalogr Clin Neurophysiol (1982) 1.32
Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol (2004) 1.31
Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs (1986) 1.31
Meptazinol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs (1985) 1.31
Carboxy-terminal regions on the surface of tubulin and microtubules. Epitope locations of YOL1/34, DM1A and DM1B. J Mol Biol (1986) 1.31
Cooperation between carrier-reactive and hapten-sensitive cells in vitro. Nat New Biol (1971) 1.30
A cell signal pathway involving laminin-5, alpha3beta1 integrin, and mitogen-activated protein kinase can regulate epithelial cell proliferation. Mol Biol Cell (1999) 1.28
Characterization of human lens major intrinsic protein structure. Invest Ophthalmol Vis Sci (2000) 1.28
Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc Natl Acad Sci U S A (1992) 1.26
Hybridization of nuclear matrix attached deoxyribonucleic acid fragments. Biochemistry (1981) 1.26
Targeting recombinant antibodies to the surface of Escherichia coli: fusion to a peptidoglycan associated lipoprotein. Biotechnology (N Y) (1991) 1.24
A genetic locus closely linked to a protease inhibitor gene complex controls the level of multiple RNA transcripts. Mol Cell Biol (1985) 1.24
High level production of soluble single chain antibodies in small-scale Escherichia coli cultures. J Immunol Methods (1997) 1.24
Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II) Br J Cancer (1995) 1.22
Carboxy-terminal amino acid sequence of alpha-tubulin from porcine brain. Nature (1979) 1.20
Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet (1999) 1.20